Calendar Companies Compare Analytics Learn Watchlist

Search CatalystAlert

Search for companies, drugs, and catalysts

Loading market movers...

Free biotech catalyst calendar tracking FDA decisions, clinical trial results, and PDUFA dates for biotech stocks.

Quick Links

Catalyst Calendar
Search Companies
Biotech Glossary
Therapeutic Areas

Legal

About
Privacy
Terms

Data Sources

ClinicalTrials.gov
SEC EDGAR
FDA

© 2025 CatalystAlert. All rights reserved.

Not financial advice. Data may be delayed or incomplete.

KSI-101 - Phase 3 | KOD Pipeline | CatalystAlert

KSI-101

Phase 3

Kodiak Sciences Inc (KOD)

50%

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Feb 2026~

KOD⭐Phase 3Phase 3

KSI-101 Phase 3 Results Expected

KSI-101 • Macular Edema Secondary to Inflammation

Drug Information

Target Indication

Macular Edema Secondary to Inflammation

Clinical Trial

Last updated: 12/4/2025

Developer

KOD

Kodiak Sciences Inc

Biotechnology•North America•NASDAQ